Objective: To systematically review the evidence for interventions addressing key domains of the
overweight/obesity and insufficient physical activity that may contribute to poorer quality of life. 11 Men with prostate cancer also have an increased risk of suicide that is especially evident in the first 12 months after diagnosis and in men with advanced disease. 12, 13 Thus, addressing the unique and long-term needs of prostate cancer survivors is critical to quality oncology care.
The importance of survivorship care was first formally recognised by the Institute of Medicine in 2005. 14 In 2014, the American Cancer Society (ACS) published specific Prostate Cancer Survivorship Care
Guidelines, which were subsequently endorsed by the American Society of Clinical Oncology (ASCO). 15, 16 These guidelines aim to promote comprehensive follow-up care, optimal health, and quality of life for men with prostate cancer with five key domains for action:
health promotion, surveillance for prostate cancer recurrence and screening for second primary cancers, management of long-term physical side effects, psychosocial management, and care coordination. The guidelines recommend that survivors maintain a healthy weight by limiting high calorific foods; engage in regular physical activity including weight-bearing exercises; consume a diet high in fruits, vegetables, and whole grains; avoid or limit alcohol consumption; and avoid smoking tobacco. In order to monitor for prostate cancer recurrence, it is recommended that prostate-specific antigen (PSA) levels are assessed every 6 to 12 months for the first 5 years after treatment, and a digital rectal examination (DRE) is performed annually. 17 As prostate cancer survivors may be at increased risk of bladder or colorectal cancers, survivors need to be monitored and symptoms referred for thorough evaluation to detect any second primary cancers early. 18 The guidelines highlight the importance of assessing and managing long-term side effects such as anaemia, bowel dysfunction, sexual dysfunction, and cardiometabolic risks, tailored for the type of cancer treatment received. 15, 16 Additionally, survivors should be routinely screened using the Distress Thermometer 19 at various stages of the cancer pathway, with patient-reported quality of life recorded at diagnosis and annually thereafter as part of survivorship care. 20 In order to improve care coordination, it is advised that cancer specialists provide all prostate cancer survivors with a survivorship care plan, incorporating both treatment summaries and clinical follow-up recommendations for primary care practitioners. 15, 16 The ACS survivorship care domains and corresponding guidelines were developed using a combination of expert consensus and an evidence synthesis that was largely observational, based on small sample sizes, and with great variability in methodologies. 15 In addition, according to the ACS process, these guidelines need to be revised every 5 years. 15 Thus, it is timely to investigate the evidence presented in systematic reviews that relate to prostate cancer survivorship care. Specifically, there is a need to synthesise the evidence regarding the overall effectiveness of various intervention types, identify conflicting evidence, and determine whether this can sufficiently inform improved guidelines for targeting care across the survivorship domains for men with prostate cancer. Accordingly, we undertook a systematic review of the evidence for interventions addressing key domains of the ACS and ASCO Prostate Cancer Survivorship Care
Guidelines: health promotion, surveillance, physical side effects, psychosocial management, and care coordination. Key objectives were to identify systematic reviews about interventions that map to these survivorship domains and evaluate the extent of evidence available to support specific approaches.
| METHODS
Systematic reviewing methods were used to identify existing reviews rather than original research. We used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist to guide the conduct and reporting of this review. 21 
| Search strategy
Electronic searches were conducted in the Cochrane Database of Systematic Reviews, the Database of Abstracts of Reviews of Effects (DARE), CINAHL, Scopus, PsycInfo, and PubMed, using the search strategies in Appendix S1. Key terms related to "prostate cancer"; AND "intervention" OR "RCT" or "trial" or "program"; AND "survivorship" OR "quality of life" OR "side effects" OR "surveillance" OR "healthy lifestyle" OR "care-coordination"; AND "review". 
| Eligibility criteria
Systematic reviews or meta-analyses examining trial studies that assessed the effectiveness of an intervention in comparison with control conditions on any outcome within a prostate cancer survivorship domain were eligible for inclusion. All titles and abstracts were independently screened, and relevant reviews were retrieved and assessed for inclusion. Any disagreement within this process was resolved through discussion within the team. Inclusion criteria were organised in accordance with the patient, intervention, comparison, outcome (PICO) reporting structure. 21 Review articles were included if they focused on populations of adult prostate cancer survivors, or where a subset of included studies investigated adult men with prostate cancer; evaluated controlled or uncontrolled trials of interventions for prostate cancer survivors; and focused on survivorship outcomes within the five domains. We excluded reviews that reported on general cancer populations or trials of mixed cancer groups, interventions that were conducted prediagnosis, and studies focusing on clinical or medical anticancer treatment only.
| Data extraction and analysis
From each eligible systematic review or meta-analysis, data were extracted relating to authors, year, objectives, participants, intervention types, outcome variables, quality assessment, and authors'
conclusions. The reviews varied in whether they grouped studies Appraisal of individual component studies was beyond the scope of this synthesis, as these were the aims of the original systematic reviews and meta-analyses.
| Quality assessment
Each systematic review was critically appraised using a modified checklist from DARE. The checklist was used to assess the reliability and validity of included review articles. 22 To be included in the current synthesis, reviews had to meet at least five of the seven criteria provided in Figure 1 . In order to assess the quality of the overall body of evidence within each domain, we relied on review authors' conclusions regarding the quality of interventions within each review. These are summarised within the presentation of results.
| RESULTS
Overall, the search identified 902 articles. After removal of duplicates and title and abstract screening, 63 articles were examined in greater detail. Of these, 46 unique systematic reviews met the inclusion criteria; however, two were excluded after quality assessment, leaving 44 review articles in the current synthesis ( Figure 2) . Overall, the included review articles reported on a total of 548 studies; however, this included only 212 unique studies, as there was significant overlap between review articles in the same domains. The reviews varied considerably in inclusion criteria and objectives. The majority of reviews were of high methodological quality, meeting all seven criteria on the DARE checklist (n = 27, 61%). The most common issues reducing review quality were not involving more than one author in each stage of the review process and not assessing the quality of the primary studies. Appendix S2 presents the main characteristics of each included review. 
| Coverage of domains
Overall, the majority of systematic reviews reported on outcomes relating to psychosocial management (n = 23), health promotion (n = 19), and physical side effects (n = 17). No reviews investigated care coordination as a primary outcome; however, three review articles reported on interventions targeting individual's self-efficacy, uncertainty, and knowledge regarding care, which could be considered a proxy for care coordination. No articles were located that systematically reviewed interventions designed to improve surveillance for recurrent cancer or screening for other primary cancers. Eleven of the included reviews (25%) conducted a meta-analysis for some or all of the primary studies, while for the majority of reviews, this was not possible due to considerable heterogeneity across studies.
| Participant characteristics
The majority of included reviews focused on a broad population of men diagnosed with prostate cancer, including men with any stage of cancer, and undergoing any treatment type. Two reviews excluded men with advanced stage of disease due to the different treatment and outcome pathways. 23, 24 Additionally, eight of the included reviews focused only on men undergoing androgen deprivation therapy (ADT), [25] [26] [27] [28] [29] [30] [31] [32] while three focused only on those undergoing radical prostatectomy, [33] [34] [35] undertaking an evaluation of the effect of exercise interventions on differing treatment-related side effects and adverse events. For the reviews investigating interventions to assist men undergoing ADT, seven reviews focused on body composition, weight gain, and cardiometabolic risk outcomes, while one review focused on depression, anxiety, and quality of life. 25 For men undergoing radical prostatectomy, the reviews focused on physical symptoms known to cause common side effects including erectile dysfunction and incontinence. Further, regarding the populations of interest in the current reviews, only one review focused on ethnic minority populations in America, 36 while one other review included three studies addressing ethnicity as a mediator. 
| Narrative synthesis
To address the second research question regarding the effectiveness of interventions in addressing singular domains of survivorship, the combined findings and conclusions of review articles published within the last 5 years are summarised in a narrative synthesis. Twenty-eight of the review articles (63%) were published after 2013, with the overall conclusions from the body of evidence presented in Table 1 .
Nine review articles assessed the effectiveness of exercise interventions on a range of outcomes across multiple domains of survivorship; thus, these reviews are included in the synthesis more than once.
| Health promotion
Eleven review articles focused on health promotion outcomes, investigating the impact of nutrition and exercise interventions on body weight, body composition, physical activity levels, and PSA levels.
Reviews in this domain of survivorship reported on nutrition (n = 4), exercise (n = 10), or combination (n = 3) interventions, which included aerobic and/or resistance training, diet, and dietary supplements. No review reported on individual studies that investigated outcomes related to smoking or alcohol consumption. Reviews investigating evidence relating to exercise interventions generally reported higherquality bodies of evidence than reviews of combination or nutrition interventions. Overall, the reviews included in the health promotion domain suggest that there is strong, high-quality evidence of the effectiveness of exercise interventions, with inconclusive evidence for nutrition interventions.
Five reviews reported that exercise interventions, such as aerobic and resistance training, could be effective in improving physical activity levels. 27, 28, 30, 38, 39 One review of diet and exercise interventions reported reductions in body weight, 40 with diet having more effect on weight loss than exercise alone. One review reported the efficacy of exercise interventions to preserve and improve lean body mass particularly in the setting of ADT, 27 while another review reported no effect in other parameters of body composition. 31 There was some evidence that particular diets and supplements can impact prostate cancer progression. Nutrition interventions that were reported to stabilise or decrease serum PSA levels tended to be low in fat and include plant-based supplements (pomegranate, flaxseed, lycopene, and soy) 41, 42 ; however, soy supplementation did not improve any outcomes in one review. 31 The overall impact of nutrition interventions on PSA levels could not be reliably estimated due to limited and low-quality trials.
| Surveillance
No review articles were retrieved that reported on interventions to improve rates of surveillance for second primary cancers and monitoring for recurrence.
| Physical side effects
Sixteen systematic review articles reported on interventions aiming to alleviate ongoing physical side effects of prostate cancer treatment in the survivorship period, including fatigue, muscle strength, peak oxygen intake, bone health, cardiovascular fitness, sexual function, and incontinence. Reviews in this domain of survivorship reported on exercise (n = 12), exercise combined with diet (n = 1), and other complex intervention types (n = 3). Overall, the body of evidence addressing the physical side effects of prostate cancer with exercise interventions was reported to be high quality. 
ACS guidelines
Counsel survivors to achieve and maintain healthy weight, and avoid or limit alcohol and tobacco products.
Measure serum PSA every 6 to 12 months, and perform annual DRE. Assess and manage long-term treatment-related side effects.
Identify, treat, and manage ongoing psychosocial effects.
Cancer specialists should provide all prostate cancer patients with a survivorship care plan.
Number of reviews 11 Diet interventions were reported to achieve significant weight loss. Individual nutrition interventions also showed some small positive impacts on PSA levels, particularly plant-based supplements, but overall there was inconclusive evidence of the effectiveness of diet interventions on PSA levels. Exercise interventions including aerobic or resistance training predominantly report improvements in QoL outcomes, particularly supervised aerobic and resistance training. Aerobic and resistance training exercise interventions reported no effect on depression or anxiety outcomes.
Reviews relating to care coordination outcomes were not identified. Limited evidence was found for psychosocial interventions targeting selfefficacy and coping, which may serve as a proxy in this domain.
Quality of evidence The bodies of evidence from exercise interventions were predominantly rated as high quality and low risk of bias, while nutrition interventions were of poorer methodological quality.
Evidence was predominantly rated as high quality with only one review of psychosocial interventions rating the body of evidence as low quality.
Psychosocial intervention evidence was rated as low to moderate in most reviews. Exercise intervention evidence rated as moderate to high quality and low risk of bias.
No reviews on care coordination identified.
Abbreviations: DRE, digital rectal exam; PSA, prostate-specific antigen; QoL, quality of life.
Five reviews suggested that a combination of aerobic and resistance training delivered during or after treatment for prostate cancer survivors could be effective in improving cardiorespiratory fitness and peak oxygen capacity, with resistance training demonstrating improvements to muscular strength. 27 29 One review also investigated the effectiveness of psychosocial interventions, such as cognitive-behavioural therapy and education, and indicated that these may have positive effects on cancer-related fatigue. 45 For incontinence outcomes, one review reported that preoperative pelvic floor training did not improve the time to incontinence above and beyond the benefits of pelvic floor exercise post-operatively, 33 while another reported that preoperative pelvic floor exercise improves early continence but not long-term continence rates in men after radical prostatectomy. 35 One review reported that pelvic floor interventions showed significant improvements on urinary symptoms both with and without biofeedback, with only three trials examining the effects on sexual function and selfesteem. 48 One review reported improvements in sexual bother, sexual confidence, and sexual satisfaction from interventions utilising psychoeducational, peer support, and cognitive-behavioural group interventions. 49 Exercise interventions were reported to have a borderline positive effect on sexual activity but no effect on sexual function. 50 
| Psychosocial management
Eighteen included systematic reviews reported on interventions that aimed to improve the psychosocial effects of cancer and treatment for prostate cancer survivors, predominantly focusing on quality of life, depression, anxiety, and mental health outcomes. Reviews in this domain of survivorship reported on the effectiveness of psychosocial (n = 5), exercise (n = 13), or nutrition (n = 3) interventions.
Five reviews reported on the effectiveness of psychosocial interventions on outcomes including quality of life, depression, anxiety, and distress. 23, 49, [51] [52] [53] Reviews with a narrower scope reported no significant effect of supportive care interventions on quality of life or depression outcomes. 23, 51 Two reviews that focused only on depression or anxiety reported that psychosocial strategies have a short-term benefit, particularly peer support and psychotherapy rather than education, but this was not sustained over time. 52, 53 One review reported small improvements in some aspects of health-related quality of life;
however, it was uncertain whether these were clinically important improvements as the evidence base was of low quality. 51 Finally, one comprehensive review with a broader scope included 56 randomised controlled trials (RCTs) and reported that combinations of cognitive behavioural, health professional communication, psychoeducation, and peer support interventions were most commonly applied and effective in improving decision-related distress, mental health, and health-related quality of life outcomes. 49 Evidence from eight reviews suggested that aerobic and resistance exercise interventions show some benefit in improving healthrelated quality of life outcomes, both during and after treatment, particularly with supervised interventions. 28, 30, 31, 44, 46, 50, 54, 55 Other reviews reported an unclear impact of exercise on quality of life 47 or insufficient data for analysis. 27, 29, 33 The effect of healthy eating on quality of life was also inconclusive as reported in three reviews. 31, 44, 54 Exercise interventions were reported to have no impact on depression or anxiety outcomes, 46 or again, there were insufficient data available. 25 
| Care coordination
No reviews investigated interventions that target care coordination.
Two supportive and psychosocial care reviews published in the last 5 years described interventions to improve self-efficacy and coping, which may be a proxy for care coordination. 23, 51 These reviews found little evidence for effectiveness in improving self-efficacy or coping in men with prostate cancer. Nevertheless, no reviews were identified that examined professional or system-led interventions to improve care coordination for prostate cancer survivorship. The lack of systematic reviews investigating monitoring for prostate cancer recurrence and surveillance of other primary cancer types may be due to an absence of interventional research examining this within survivorship. Several reviews have focused on interventions that aim to increase the uptake of PSA testing to screen for prostate cancer and assess the effect on incidence and diagnosis rates [56] [57] [58] [59] ;
but limited studies have investigated interventions designed to target PSA testing after diagnosis. Follow-up testing and ongoing surveillance is an important aspect of survivorship care, helping to detect recurrence and monitor for diagnosis of other primary cancers, and is of particular importance for patients undergoing active surveillance. 15 The monitoring guidelines in the ACS/ASCO framework are based on expert consensus, and while experts agree that routine monitoring is necessary, the exact intervals and recommendations for surveillance vary depending on clinical and treatment factors and continue to evolve. 60 Research from America, Australia, and Europe has reported that many men undergoing active surveillance may not be adhering to the recommended surveillance protocols, with between 13% and 30% of patients not adhering to PSA and biopsy testing guidelines in the first 2 years postdiagnosis. [61] [62] [63] Evidence suggests that exercise interventions can delay the transition to active therapy in men undergoing active surveillance and current RCTs are underway to investigate further. 64, 65 Until data are routinely collected and reported on individuals' adherence to routine monitoring and surveillance guidelines, for those undergoing active surveillance, ADT, and other treatments, it cannot be determined whether other interventions are necessary. Thus, this remains a neglected survivorship domain in the literature, which requires further attention.
There was no review evidence relating to the care coordination domain of survivorship. The ACS guidelines recommend that all patients are given a survivorship care plan by the treating specialist and that specialists and primary care providers discuss the care plan components and are involved in shared care. 15 76 We propose that the guidelines need to be updated to reflect information matched to the particular needs of individual men. need. 49 In this regard, the application of stepped or tiered care models where intervention is matched to the depth of needed and stepped up when required through the use of regular screening and assessment is a needed future direction. 77 Future research is needed to examine the acceptability and effectiveness of exercise and psychosocial interventions in more diverse populations, and strategies to support optimal translation into routine clinical practice are needed. In a controlled trial, the benefits of specific exercise regimes compared with usual care can be clearly tested;
however, there is limited evidence of these interventions being scaled effectively to reach large sections of the population in real-world settings. For such interventions to be successfully implemented population wide, this relies on strategies for motivating men to engage in self-directed exercise. This may be particularly difficult for men who have not previously exercised or who experience physical constraints or side effects. An intervention that involved 6 months of supervised exercise followed by 6 months of self-directed exercise showed that men were able to preserve improvements in cardiorespiratory fitness, physical function, muscle strength, and self-reported physical functioning that took place within the first 6 months, 78 providing a potential strategy to overcome the self-motivation issue. Again, for psychosocial interventions that have been shown to be effective in a controlled trial environment, further understanding of how these can be implemented into practice is required, as limited work has investigated the feasibility of scaling to larger populations. Future trials also need to assess how to sustain intervention effects over a longer follow-up period. Thus, there is work to be done before translating targeted interventions suited to the diverse range of patients who are diagnosed with prostate cancer into practice. 79 
| Study limitations
This synthesis of systematic reviews provides an overview of current evidence on the effectiveness of a variety of interventions on health and well-being outcomes across the five domains of prostate cancer survivorship. By bringing together evidence from extensive previously published literature, this synthesis provides insight into the current state of research in the area; however, there are some limitations that need to be acknowledged. The reviews of interest included a wide variety of intervention types, study designs, and outcomes measures, making it challenging to compare and to identify similar themes across different reviews. Additionally, the reporting of quality assessments was also lacking in some cases, and many included reviews provided a narrative synthesis rather than a meta-analysis and did not report odds ratios or effect sizes due to the heterogeneity of primary studies.
The search terms and search logic were not overseen by a certified medical librarian, and although a thorough search of pertinent databases was conducted by two authors, we also cannot guarantee that some relevant reviews may not have been located.
| Clinical implications
This review highlights the need for contemporary prostate cancer survivorship interventions that address all relevant survivorship domains, with an integrated or multicomponent approach that builds synergies between approaches. Methods for developing, testing, and implementing complex interventions are now well described, 80 and the application of these will help ensure that feasibility for implementation at scale is a priority. Men with prostate cancer often experience long-term decrements in quality of life and psychological well-being as a result of their cancer experience. Long-term survivorship care that is responsive to their specific concerns is crucial.
| CONCLUSIONS
The five domains of the ACS Prostate Cancer Survivorship Care
Guidelines provide a framework for comprehensive follow-up care
and optimal health and quality of life for men with prostate cancer.
Without high-quality evidence, solutions to improving outcomes among prostate cancer survivors will continue to be obscured to clinicians, researchers, and policymakers. While there is evidence for the effectiveness of exercise and psychosocial interventions for men with prostate cancer in three of the five domains, methods for successfully scaling these interventions to large populations are not well described, nor is the optimal approach to tailoring for specific needs well understood. In addition, for surveillance and care coordination, review evidence is absent and this must serve as a concern for all interested in the welfare of men with prostate cancer and their families. Recent advances in prostate cancer treatment and care have led to increased survival for men with prostate cancer. Our review highlights the need for survivorship interventions to be developed, tested, and proven at a similar pace to the rate of progress in anticancer therapies. Priority therefore needs to be given to research that identifies ways to provide an effective range of interventions to meet the survivorship needs of men with prostate cancer.
